GnRH restrictions extended again

The Government has made The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) (No. 2) Order 2024, which has the effect of extending the ban, which was due to expire.

The ban has now been extended until 31 December 2024.

A consultation took place in 2023 into the use of these medicines. The aim of the extension is to allow the Government time to consider the next steps, including to make the ban permanent.

The ban was previously extended in August.

Clinical guidance news

Latest news

Alert: Tropicamide 1% eye drops; Co-amoxiclav 250/62.5 mg/5 ml powder

Aspire Pharma Ltd is recalling three batches of Tropicamide 1% eye drops, solution in single dose containers 20 x 0.5ml. The recall is due to incorrect expiry dates. The affected batches are: Batch No. Expiry Date Pack Size Fir

DDA meets MPs to discuss increasing cost pressures

The increasing cost pressures on dispensing practice have been highlighted by the DDA in a drop-in meeting with cross party MPs. Facilitated by Labour MP (Buckingham & Bletchley) Callum Anderson, the meeting saw DDA senior leaders meet with MPs

Rising dispensing GP cost pressures recognised by CMO

The chief medical officer (CMO) for England has recognised the increased cost pressures on dispensing practices in his latest report, Health in rural areas and small towns. The report stresses that practices are closing or reducing their vital servi